Practical Considerations and Implementation of Sodium-Glucose Co-Transporter-2 Inhibitors in Chronic Kidney Disease: Who, When, and How? A Position Statement by Nephrologists

• Asıl Yazarlar: Anjay Rastogi (Yazar), Ashté Collins (Yazar), Ellie Kelepouris (Yazar), Wayne Kotzker (Yazar), John P. Middleton (Yazar), Minesh Rajpal (Yazar), Prabir Roy-Chaudhury (Yazar), Glenn M. Chertow (Yazar)
• Materyal Türü: Kitap
• Baskı/Yayın Bilgisi: SAGE Publishing, 2024-08-01T00:00:00Z.
• Konular: article
• Online Erişim: Connect to this object online.

Introduction: There remains an unmet need to reduce kidney and cardiovascular risk in patients with chronic kidney disease (CKD). This report is therefore intended to provide real-world clinical guidance to primary care providers on sodium-glucose co-transporter-2 (SGLT2) inhibitor use in patients w...